Palm Grove Pharmaceuticals Corporation – Trademark Portfolio

Entity Type: 03

Palm Grove Pharmaceuticals Corporation holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The owner is based in Road Town, Tortola.

Palm Grove House

P.O. Box 438

Road Town, Tortola VG1110 , VG

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

A/B OTIC
A/B OTIC
Abandoned 2009
CHISAN
CHISAN
Abandoned 2007
ZANAFLU
ZANAFLU
Abandoned 2007
MELFAST
MELFAST
Abandoned 2007
BEVITA
BEVITA
Abandoned 2007
RELAMINE
RELAMINE
Cancelled 2006
RANAMINE
RANAMINE
Cancelled 2006
PRYFLEX
PRYFLEX
Abandoned 2006
ZYCOSE
ZYCOSE
Abandoned 2006
ADACOSE
ADACOSE
Abandoned 2006
BONISARA
BONISARA
Cancelled 2006
OMNIELLE
OMNIELLE
Abandoned 2006
CYTAFLEX
CYTAFLEX
Abandoned 2006
CYTAC
CYTAC
Cancelled 2006

Trademark Classifications

Palm Grove Pharmaceuticals Corporation's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Palm Grove Pharmaceuticals Corporation have?

Palm Grove Pharmaceuticals Corporation has 16 U.S. trademarks filed with the USPTO.

What trademark classes does Palm Grove Pharmaceuticals Corporation file in?

Palm Grove Pharmaceuticals Corporation files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Palm Grove Pharmaceuticals Corporation's trademark registration success rate?

Palm Grove Pharmaceuticals Corporation has a 0% trademark registration rate, with 0 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.